0.32
price down icon0.56%   -0.0015
after-market Dopo l'orario di chiusura: .33 0.01 +3.13%
loading
Precedente Chiudi:
$0.3215
Aprire:
$0.3226
Volume 24 ore:
545.51K
Relative Volume:
0.52
Capitalizzazione di mercato:
$22.84M
Reddito:
-
Utile/perdita netta:
$-30.01M
Rapporto P/E:
-0.2623
EPS:
-1.22
Flusso di cassa netto:
$-23.94M
1 W Prestazione:
-4.85%
1M Prestazione:
-32.69%
6M Prestazione:
-68.35%
1 anno Prestazione:
-56.50%
Intervallo 1D:
Value
$0.3036
$0.35
Intervallo di 1 settimana:
Value
$0.3036
$0.3618
Portata 52W:
Value
$0.217
$2.48

In 8 Bio Inc Stock (INAB) Company Profile

Name
Nome
In 8 Bio Inc
Name
Telefono
(646) 600-6438
Name
Indirizzo
EMPIRE STATE BUILDING, NEW YORK
Name
Dipendente
18
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
INAB's Discussions on Twitter

Confronta INAB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
INAB 0.32 22.84M 0 -30.01M -23.94M -1.22
VRTX 450.37 115.43B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 24.89B 3.30B -501.07M 1.03B 11.54

In 8 Bio Inc Stock (INAB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-08-30 Iniziato H.C. Wainwright Buy

In 8 Bio Inc Borsa (INAB) Ultime notizie

pulisher
08:49 AM

GRI Bio Showcases GRI-0621's Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF) - The Manila Times

08:49 AM
pulisher
08:16 AM

Palisade Bio to Present Preclinical Results for PALI-2108 - GlobeNewswire

08:16 AM
pulisher
Nov 18, 2024

10 Biggest Biotechnology Companies - Investopedia

Nov 18, 2024
pulisher
Nov 18, 2024

TāStation®'s analytical power used to resolve a central question about sweet taste perception - EurekAlert

Nov 18, 2024
pulisher
Nov 18, 2024

Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024 - The Manila Times

Nov 18, 2024
pulisher
Nov 18, 2024

Intevac (NASDAQ: IVAC) Enters into Letter Agreement with Palogic Value Management, L.P.Santa Clara, CA, November 13, 2024 – Intevac, Inc. (NASDAQ: IVAC) disclosed today in a Form 8-K filing that on November 8, 2024, the company entered into a letter - Defense World

Nov 18, 2024
pulisher
Nov 18, 2024

Sound Point Meridian Capital, Inc. (NYSE: SPMC) Announces Financial Results for Quarter Ended September 30, 2024 - Defense World

Nov 18, 2024
pulisher
Nov 18, 2024

Roth CH Acquisition II Files 8-K Report with SEC Detailing Company Updates and Investor Presentation - Defense World

Nov 18, 2024
pulisher
Nov 18, 2024

Capricor Therapeutics Announces Financial Results for Third Quarter 2024 and Strategic DevelopmentsSAN DIEGO, November 13, 2024 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR) recently disclosed its financial outcomes for the third - Defense World

Nov 18, 2024
pulisher
Nov 18, 2024

Predictive Oncology Inc. Issues Press Release Detailing Financial Results for Q3 2024Predictive Oncology Inc., a leading biopharmaceutical company, released a pivotal press release detailing its financial results for the quarter ending September 30 - Defense World

Nov 18, 2024
pulisher
Nov 18, 2024

Broadwind, Inc. Reports Financial Results for Quarter Ending September 30, 2024 - Defense World

Nov 18, 2024
pulisher
Nov 15, 2024

Gritstone bio : Bankruptcy Form 8 K - Marketscreener.com

Nov 15, 2024
pulisher
Nov 15, 2024

US$8.25: That's What Analysts Think 2seventy bio, Inc. (NASDAQ:TSVT) Is Worth After Its Latest Results - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

bluebird bio, Inc. (NASDAQ:BLUE) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024
pulisher
Nov 15, 2024

bluebird bio Inc (BLUE) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... - Yahoo Finance

Nov 15, 2024
pulisher
Nov 14, 2024

SEC Form SC 13G filed by Bio-Rad Laboratories Inc. - Quantisnow

Nov 14, 2024
pulisher
Nov 14, 2024

bluebird bio Reports Third Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance - BioSpace

Nov 14, 2024
pulisher
Nov 14, 2024

Palisade Bio CMO Mitch Jones, MD, PhD, to Present at 8th Annual Antifibrotic Drug Development (AFDD) Summit - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

NJ Bio, Inc. Wins Best CRO Award at 15th Annual World ADC Conference - Joplin Globe

Nov 14, 2024
pulisher
Nov 13, 2024

Kronos Bio : Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives Form 8 K - Marketscreener.com

Nov 13, 2024
pulisher
Nov 12, 2024

Mustang Bio Receives Positive Listing Determination from Nasdaq - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Annovis Invited to Present at National Institute on Aging Workshop on Dementia with Lewy Bodies (DLB) - Quantisnow

Nov 12, 2024
pulisher
Nov 12, 2024

2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress - Business Wire

Nov 12, 2024
pulisher
Nov 11, 2024

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Nov 11, 2024
pulisher
Nov 11, 2024

Annovis Bio Reports Third Quarter Financial Results and Provides Business Update - GlobeNewswire

Nov 11, 2024
pulisher
Nov 11, 2024

Gossamer Bio Grants 183K Stock Options to New Hires at $0.88 Per Share | GOSS Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 09, 2024

BioRestorative Therapies Enters at-the-Market Offering Agreement with Rodman & Renshaw LLC - Defense World

Nov 09, 2024
pulisher
Nov 09, 2024

National Fuel Gas Updates Investor Presentation in Current ReportNational Fuel Gas Company (NYSE: NFG) has made notable updates to its Investor Presentation as detailed in a recent 8-K filing with the Securities and Exchange Commission on November - Defense World

Nov 09, 2024
pulisher
Nov 08, 2024

BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES - The Malaysian Reserve

Nov 08, 2024
pulisher
Nov 08, 2024

Annovis Bio Inc (ANVS) Quarterly 10-Q Report - Quartzy

Nov 08, 2024
pulisher
Nov 08, 2024

Telesis Bio: Q3 Earnings Snapshot - New Haven Register

Nov 08, 2024
pulisher
Nov 08, 2024

TELA Bio Inc (TELA) Quarterly 10-Q Report - Quartzy

Nov 08, 2024
pulisher
Nov 08, 2024

Mustang Bio Inc (MBIO) Quarterly 10-Q Report - Quartzy

Nov 08, 2024
pulisher
Nov 08, 2024

Pharma Pulse 11/8/24: Dusting Off One’s Cost Center Hat, Iron Supplements Benefit Children with HIV & more - Pharmaceutical Executive

Nov 08, 2024
pulisher
Nov 07, 2024

TELA Bio Reports Third Quarter 2024 Financial Results - The Bakersfield Californian

Nov 07, 2024
pulisher
Nov 07, 2024

bluebird bio Adjourns Meeting of Stockholders and Announces Third Quarter 2024 Results Call - BioSpace

Nov 07, 2024
pulisher
Nov 06, 2024

Secura Bio Announces Poster Presentation Highlighting New - GlobeNewswire

Nov 06, 2024
pulisher
Nov 06, 2024

bluebird bio Adjourns Meeting of Stockholders and Announces Third Quarter Results Call - Business Wire

Nov 06, 2024
pulisher
Nov 06, 2024

[Latest] Global Cancer Cell Analysis Market Size/Share - GlobeNewswire

Nov 06, 2024
pulisher
Nov 06, 2024

Secura Bio Announces Poster Presentation Highlighting New COPIKTRA® (duvelisib) Data for the Treatment of Patients With Peripheral T-Cell Lymphoma and Other Advanced Hematologic Malignancies at the 2024 American Society of Hematology Meeting - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Nuvation Bio Inc. (NUVB): Promising Penny Stock with Strong Oncology Pipeline - Yahoo Finance

Nov 06, 2024
pulisher
Nov 05, 2024

Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company's Novel Business Model as Key to Sustainable Success through Patient Affordability - Quantisnow

Nov 05, 2024
pulisher
Nov 04, 2024

2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference - StockTitan

Nov 04, 2024
pulisher
Oct 31, 2024

bluebird bio (BLUE): Promising Gene Editing Stock with FDA-Approved Therapies - Yahoo Finance

Oct 31, 2024
pulisher
Oct 25, 2024

OrbiMed Advisors LLC Reduces Stake in TELA Bio Inc - Yahoo Finance

Oct 25, 2024
pulisher
Oct 25, 2024

Highbridge Capital Management's Strategic Acquisition of INmune Bio Inc Shares - Yahoo Finance UK

Oct 25, 2024
pulisher
Oct 23, 2024

Upstream Bio Rings the Opening Bell - Nasdaq

Oct 23, 2024
pulisher
Oct 23, 2024

Tevogen Bio’s Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development - Yahoo Finance UK

Oct 23, 2024
pulisher
Oct 18, 2024

MicuRx Pharmaceuticals Showcases the Pipeline Status of MRX-5 and MRX-8 at BIO Investor Forum - Lelezard

Oct 18, 2024
pulisher
Oct 17, 2024

Average rate on a 30-year mortgage in the US rises to the highest level in 8 weeks - Yahoo Finance

Oct 17, 2024
pulisher
Oct 17, 2024

Cresco Labs to Report Third Quarter 2024 Financial Results on November 8, 2024 - Yahoo Finance

Oct 17, 2024

In 8 Bio Inc Azioni (INAB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.56%
$367.36
price up icon 0.77%
$194.56
price up icon 0.07%
$108.23
price up icon 5.98%
Capitalizzazione:     |  Volume (24 ore):